Residency · Grand Rapids, MI
Sponsored by Corewell Health – Grand Rapids/Michigan State University
Onasemnogene abeparvovec for presymptomatic infants with two copies of SMN2 at risk for spinal muscular atrophy type 1: the Phase III SPR1NT trial.
Nature medicine · 2022 · 263 citations · Jena Krueger
Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial.
Nature medicine · 2022 · 236 citations · Jena Krueger
Spinal Muscular Atrophy Update in Best Practices: Recommendations for Treatment Considerations.
Neurology. Clinical practice · 2025 · 25 citations · Jena Krueger
American Clinical Neurophysiology Society Technical Standards for Electrical Stimulation With Intracranial Electrodes for Functional Brain Mapping and Seizure Induction.
Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society · 2025 · 20 citations · Ammar Kheder
A multi-center comparison of surgical techniques for corpus Callosotomy in pediatric drug-resistant epilepsy.
Epilepsia · 2024 · 24 citations · Ammar Kheder
Safety and efficacy of apitegromab in nonambulatory type 2 or type 3 spinal muscular atrophy (SAPPHIRE): a phase 3, double-blind, randomised, placebo-controlled trial.
The Lancet. Neurology · 2025 · 17 citations ·
Gene Therapy for Genetic Syndromes: Understanding the Current State to Guide Future Care.
Biotech (Basel (Switzerland)) · 2024 · 22 citations · Jena Krueger
Epilepsy surgery in children with genetic etiologies: A prospective evaluation of current practices and outcomes.
Seizure · 2023 · 16 citations · Ammar Kheder